
|Articles|March 22, 2007
Vasogen Names Terry H. Gregg President and CEO
Author(s)BioPharm International Editors
Vasogen, Inc. (Ontario, Canada, www.vasogen.com), has appointed Terrance H. Gregg to succeed David G. Elsley as president and CEO of Vasogen.
Advertisement
Vasogen, Inc. (Ontario, Canada,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5




